Autoimmune hepatitis is a chronic condition where the immune system mistakenly attacks the liver, causing inflammation and potential long-term damage. While there is no cure, modern treatments can control the disease, reduce symptoms, and help many patients live normal lives—though managing this condition often requires lifelong commitment and careful monitoring.

Understanding Treatment Goals and the Path Forward

When a person receives a diagnosis of autoimmune hepatitis, the first thing many want to know is how to stop the disease from progressing. The main goal of treatment is to calm the inflammation in the liver caused by the immune system’s attack. By reducing this inflammation, doctors aim to prevent serious complications such as cirrhosis, which is scarring of the liver tissue, and ultimately liver failure. Treatment also focuses on improving symptoms like fatigue, abdominal discomfort, and jaundice, which can significantly affect daily life.^[1][8]

The approach to treating autoimmune hepatitis depends on several factors. These include how active the disease is, what stage it has reached, whether the patient already has cirrhosis, and how well the patient tolerates different medications. Some people with very mild disease and no symptoms may not need immediate treatment, but most patients will require medications to suppress the immune system. Early treatment is especially important because it can prevent liver damage from worsening and improve long-term outcomes.^[9][14]

Standard treatments approved by medical societies have been in use for decades and are effective for many patients. However, not everyone responds the same way to these treatments. Some people achieve complete remission, where the disease becomes inactive and symptoms disappear. Others may experience only partial improvement or may struggle with side effects from medications. This is why ongoing research into new therapies is so important. Clinical trials are currently testing innovative treatments that may offer better control of the disease with fewer side effects for patients who don’t respond well to standard care.^[13][14]

Standard Treatments: The Foundation of Care

For more than four decades, doctors have relied on medications called corticosteroids to treat autoimmune hepatitis. These drugs work by suppressing the immune system so it stops attacking the liver. The most commonly prescribed corticosteroid is prednisone. When treatment begins, doctors typically start with a relatively high dose of prednisone to quickly bring the inflammation under control. Over the following months, they gradually reduce the dose to minimize side effects while maintaining control of the disease.^[8][9]

Prednisone can be very effective at reducing liver inflammation, but long-term use comes with significant risks. Patients taking prednisone for extended periods may develop serious side effects including diabetes, weakened bones that can lead to fractures (a condition called osteoporosis), high blood pressure, cataracts in the eyes, glaucoma, and substantial weight gain. These side effects can be difficult to manage and may affect quality of life. To help reduce these risks, many doctors prescribe prednisone at high doses initially but aim to lower the dose as soon as the disease is under control.^[8][17]

Because of the side effects associated with prednisone, doctors often add a second medication called azathioprine (sold under brand names Azasan or Imuran). Azathioprine is an immunosuppressant, meaning it also works to calm the immune system. Adding azathioprine to the treatment plan allows doctors to reduce the dose of prednisone more quickly, or even stop prednisone altogether in some cases, while still keeping the disease under control. This combination therapy has become the standard approach for many patients with autoimmune hepatitis.^[8][9]

Azathioprine itself can cause side effects, though they differ from those of prednisone. Some patients may experience allergic reactions, inflammation of the pancreas (an organ that helps with digestion), abnormal liver blood test results, or nausea. There is also a small increased risk of developing certain cancers with long-term use of immunosuppressants. Despite these risks, for many patients the benefits of controlling the disease outweigh the potential side effects. Another medication similar to azathioprine, called 6-mercaptopurine (Purinethol), may be used as an alternative for patients who cannot tolerate azathioprine.^[9][14]

The goal of standard treatment is to achieve what doctors call remission. Remission means the inflammation in the liver has stopped or decreased significantly, liver blood tests return to normal or near-normal levels, and symptoms improve or disappear. Many patients with autoimmune hepatitis do achieve remission with treatment. Blood tests measuring liver enzymes called ALT (alanine aminotransferase) and AST (aspartate aminotransferase) help doctors monitor whether the treatment is working. When these enzyme levels fall to normal, it’s a sign that liver inflammation is under control.^[9][11]

Treatment duration varies considerably among patients. Some people achieve remission within a year or two, while others need to take medications for many years or even for life. If a patient stays in remission for at least two years, doctors may try gradually stopping medications to see if the disease stays quiet without them. However, many patients experience a relapse, where the disease becomes active again after stopping treatment. When this happens, medications need to be restarted. Because of the high risk of relapse, most patients require long-term, often lifelong, treatment with low doses of immunosuppressive medications to keep the disease under control.^[9][14]

For patients who don’t respond to standard treatment with prednisone and azathioprine, doctors may try alternative medications. These include drugs like mycophenolate mofetil, tacrolimus, cyclosporine, or budesonide. Studies have shown that approximately 20 to 24% of patients either don’t respond completely to the standard combination therapy or don’t respond at all. For these individuals with “difficult to treat” autoimmune hepatitis, finding the right medication or combination of medications may take time and require close collaboration with a liver specialist.^[13][14]

In rare cases where autoimmune hepatitis progresses despite treatment and leads to severe liver failure or cirrhosis with serious complications, liver transplantation may become necessary. A liver transplant involves surgically removing the damaged liver and replacing it with a healthy liver from a donor. Fortunately, with modern treatments, most patients don’t progress to the point of needing a transplant. Studies suggest that after 10 years of treatment, about 9 to 10% of patients needed a liver transplant or died from liver-related disease. After 20 years, about 30% needed a transplant or experienced liver-related death. Early diagnosis and consistent treatment greatly improve the chances of avoiding transplantation.^[8][16]

Treatment in Clinical Trials: Hope for the Future

While standard treatments work for many people with autoimmune hepatitis, researchers continue to search for better options. Clinical trials are research studies where new treatments are tested to see if they’re safe and effective. For autoimmune hepatitis, several innovative approaches are being explored that could change how the disease is treated in the future.^[13]

One area of research focuses on understanding the specific immune system problems that cause autoimmune hepatitis. Scientists have discovered that certain types of immune cells called T-regulatory cells or Tregs don’t work properly in people with autoimmune hepatitis. Tregs normally act like traffic controllers for the immune system, telling other immune cells what to attack and what to leave alone. In autoimmune hepatitis, Tregs fail to prevent immune cells called CD4+ and CD8+ T cells from attacking the liver. Researchers are working on therapies that could restore the proper function of Tregs, which would address the root cause of the disease rather than just suppressing the entire immune system.^[13]

Clinical trials for autoimmune hepatitis typically progress through three phases. Phase I trials test a new treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects. Phase II trials involve more participants and focus on whether the treatment actually works—in this case, whether it reduces liver inflammation and improves liver function. Phase III trials compare the new treatment directly with the standard treatment to see which works better and have fewer side effects. These trials involve even larger groups of patients and provide the most robust evidence about whether a new therapy should become part of standard care.^[7]

Some clinical trials are exploring biological therapies, which are treatments made from living cells or proteins designed to target very specific parts of the immune system. Unlike traditional immunosuppressants that broadly suppress the entire immune system, biological therapies aim to block only the specific immune pathways causing liver damage. This targeted approach could potentially reduce side effects while maintaining or improving disease control. Examples might include antibodies that block specific inflammatory signals or therapies that boost the function of regulatory immune cells.^[13]

Other research is examining whether existing medications used for different autoimmune diseases might also help patients with autoimmune hepatitis. This approach, called drug repurposing, can speed up the process of finding new treatments because these medications have already been tested for safety in humans. If researchers find that a drug approved for, say, rheumatoid arthritis also helps control liver inflammation in autoimmune hepatitis, it could become available to patients much faster than a completely new medication would.^[13]

Participating in a clinical trial can offer patients access to new treatments before they’re widely available. However, it’s important to understand that experimental treatments may not work as well as hoped, and they may have unexpected side effects. Clinical trials also typically require more frequent doctor visits and monitoring than standard care. Patients interested in clinical trials should discuss the potential benefits and risks with their doctor. Trial locations vary, with studies conducted at medical centers throughout the United States, Europe, and other parts of the world. Eligibility criteria differ among trials, but generally include factors like disease severity, previous treatments tried, and overall health status.^[20]

Most Common Treatment Methods

• Corticosteroids
  • Prednisone is typically the first medication prescribed, starting at a high dose and gradually decreasing over several months to control inflammation while minimizing side effects
  • Can cause long-term side effects including diabetes, bone weakening, high blood pressure, cataracts, glaucoma, and weight gain
  • Effective at reducing liver inflammation in most patients when used appropriately
• Immunosuppressants
  • Azathioprine (Azasan, Imuran) is commonly added to treatment to allow reduction of prednisone dose
  • 6-mercaptopurine (Purinethol) may be used as an alternative to azathioprine
  • May cause side effects including allergic reactions, pancreas inflammation, and increased cancer risk with long-term use
  • TPMT testing recommended before starting azathioprine to identify patients at risk for serious side effects
• Alternative Immunosuppressive Medications
  • Mycophenolate mofetil, tacrolimus, cyclosporine, or budesonide may be tried for patients who don’t respond to standard treatment
  • Used in approximately 20-24% of patients who have incomplete response or don’t respond to prednisone and azathioprine
• Liver Transplantation
  • Reserved for patients with severe liver failure or advanced cirrhosis despite medical treatment
  • About 9-10% of patients need transplant or experience liver-related death after 10 years; 30% after 20 years
  • Involves surgical replacement of damaged liver with healthy donor liver
• Biological Therapies (Clinical Trials)
  • Experimental treatments targeting specific immune pathways causing liver damage
  • Designed to be more targeted than traditional immunosuppressants
  • May include therapies to restore regulatory T cell function

Living With Treatment: What to Expect

Managing autoimmune hepatitis is a long-term commitment that requires regular medical care and monitoring. Patients typically need frequent appointments with their doctor or liver specialist, especially when first starting treatment or adjusting medications. Blood tests to check liver enzyme levels, overall liver function, and blood cell counts are performed regularly to make sure the treatment is working and not causing harmful side effects. The frequency of these appointments and tests depends on how active the disease is and how well it’s controlled.^[15][19]

Some patients may experience what’s called a flare, which is when liver inflammation increases even while taking medication. Flares can happen for several reasons. Sometimes the medication dose isn’t quite strong enough to keep inflammation completely under control. Other times, a viral illness, significant stress, or another condition affecting the liver (like fatty liver disease) can trigger increased inflammation. Patients who don’t take their medications consistently also have a higher risk of flares. During a flare, symptoms like fatigue, itching, joint pain, and digestive problems may return or worsen. It’s important to report any significant changes in symptoms to a doctor, who may need to adjust medications.^[16]

One encouraging finding from research is that liver scarring, or fibrosis, may actually improve or reverse in some patients whose inflammation is well controlled with treatment. Studies have found that over half of treated autoimmune hepatitis patients showed some reduction in liver fibrosis on follow-up liver biopsies. This improvement may even be possible for patients who already have cirrhosis at diagnosis. However, these findings come from older, small studies, and it’s not possible to predict which patients will see fibrosis improvement or how long it might take. Maintaining excellent control of liver inflammation—keeping liver enzyme and immunoglobulin levels normal or low-normal—appears to be important for the possibility of reversing fibrosis.^[16]

Lifestyle adjustments can also support overall health while living with autoimmune hepatitis. Avoiding alcohol is crucial, as alcohol can cause additional liver damage on top of the disease itself. Patients should inform their doctors about all medications they take, including over-the-counter drugs and supplements, because some can harm the liver. For example, acetaminophen (found in Tylenol and many other products) can damage the liver when taken in large amounts or combined with alcohol. A low-salt diet may be recommended for patients who develop fluid buildup in the abdomen, called ascites. Regular, moderate physical activity can help maintain overall health, though patients should adjust activity levels to match their energy.^[19][20]

The emotional and psychological impact of living with a chronic disease shouldn’t be underestimated. Autoimmune hepatitis can cause fatigue that goes beyond normal tiredness, affecting the ability to work, care for family, or enjoy activities. The need for lifelong medication and monitoring, along with concerns about disease progression, can lead to anxiety or depression. Finding support through patient organizations, online support groups, or mental health professionals can make a significant difference in quality of life. Connecting with others who understand the challenges of living with autoimmune hepatitis helps many people feel less isolated.^[20][21]

Despite the challenges, the outlook for most patients with autoimmune hepatitis is quite good with proper treatment. Studies show that 91% of treated patients are still living after 10 years, and 70% are still living after 20 years without needing liver transplants. Many patients achieve remission and maintain normal or nearly normal life expectancy. The key is early diagnosis, consistent treatment, regular monitoring, and open communication with healthcare providers about any concerns or changes in symptoms.^[16]